v3.26.1
SHARE CAPITAL (Narrative) (Details 1)
 1 Months Ended 12 Months Ended
Oct. 01, 2025
Share
$ / shares
Nov. 25, 2025
Share
$ / shares
Mar. 31, 2026
CAD ($)
Share
$ / shares
Mar. 31, 2025
CAD ($)
Share
$ / shares
Disclosure of classes of share capital [line items]        
Share-based compensation | $     $ 1,256,134 $ 1,529,934
Consultants, employees, officers and directors [Member]        
Disclosure of classes of share capital [line items]        
Number of stock options granted     1,579,000 2,000,000
Exercise price | $ / shares     $ 1.06  
Grant date fair value of stock options granted | $     $ 927,879 $ 1,802,247
Description of vesting period     The vesting period for the stock options issued was as follows: 504,583 at the date of issuance; 504,583 after 12 months from the date of issuance; 504,583 after 24 months from the date of issuance; and 65,250 after 36 months from the date of issuance. The vesting period for the stock options issued was as follows: 621,250 at the date of issuance; 661,250 after 12 months from the date of issuance; 621,250 after 24 months from the date of issuance; and 96,250 after 36 months from the date of issuance.
Consultants, employees, officers and directors [Member] | Minimum [Member]        
Disclosure of classes of share capital [line items]        
Exercise price | $ / shares       $ 1.42
Consultants, employees, officers and directors [Member] | Maximum [Member]        
Disclosure of classes of share capital [line items]        
Exercise price | $ / shares       $ 1.52
Triera Biosciences Ltd [Member]        
Disclosure of classes of share capital [line items]        
Number of stock options granted     0 5,000
Triera Biosciences Ltd [Member] | Consultants [Member]        
Disclosure of classes of share capital [line items]        
Number of stock options granted       5,000
Exercise price | $ / shares       $ 1
Description of vesting period       The vesting period for the Triera stock options issued was as follows: 1,667 on June 1, 2024; 1,667 on June 1, 2025; and 1,666 on June 1, 2026.
Restricted Stock Units [Member]        
Disclosure of classes of share capital [line items]        
Number of units granted 654,000 425,000    
Fair value of each restricted share unit | $ / shares $ 1.06 $ 1.08    
Number of units expired 58,000      
Number of units outstanding 596,000      
Share-based compensation | $     $ 469,171 $ 0